CGT
ABBV icon

Capital Guardian Trust’s AbbVie ABBV Stock Holding History

Capital Guardian Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$9.52M Sell
130,955
-11,382
-8% -$895K 0.13% 135
2019
Q1 		$11.8M Buy
142,337
+22,037
+18% +$1.8M 0.16% 123
2018
Q4 		$11.1M Sell
120,300
-1,400
-1% -$123K 0.18% 120
2018
Q3 		$11.5M Buy
121,700
+35,300
+41% +$3.35M 0.16% 123
2018
Q2 		$8.01M Sell
86,400
-9,800
-10% -$957K 0.11% 130
2018
Q1 		$9.11M Buy
96,200
+17,100
+22% +$1.88M 0.13% 135
2017
Q4 		$7.65M Buy
79,100
+63,000
+391% +$5.94M 0.11% 146
2017
Q3 		$1.43M Buy
+16,100
New +$1.23M 0.02% 155
2017
Q2 		– Sell
-11,438
Closed -$745K – 203
2017
Q1 		$745K Sell
11,438
-1,433
-11% -$90.1K 0.01% 252
2016
Q4 		$806K Sell
12,871
-17,155
-57% -$1.05M 0.01% 261
2016
Q3 		$1.89M Buy
30,026
+9,258
+45% +$599K 0.01% 227
2016
Q2 		$1.29M Sell
20,768
-12,700
-38% -$774K 0.01% 242
2016
Q1 		$1.91M Sell
33,468
-499,288
-94% -$27.8M 0.01% 225
2015
Q4 		$31.6M Sell
532,756
-413,866
-44% -$23.8M 0.25% 120
2015
Q3 		$51.5M Sell
946,622
-135,615
-13% -$8.83M 0.42% 93
2015
Q2 		$72.7M Sell
1,082,237
-239,546
-18% -$15.6M 0.52% 70
2015
Q1 		$77.4M Sell
1,321,783
-303,539
-19% -$18.3M 0.57% 66
2014
Q4 		$106M Sell
1,625,322
-450,019
-22% -$28.4M 0.74% 53
2014
Q3 		$120M Sell
2,075,341
-50,242
-2% -$2.79M 0.85% 43
2014
Q2 		$120M Buy
2,125,583
+415,442
+24% +$21.8M 0.82% 47
2014
Q1 		$87.9M Buy
1,710,141
+762,962
+81% +$38.6M 0.59% 57
2013
Q4 		$50M Buy
947,179
+157,953
+20% +$7.76M 0.33% 89
2013
Q3 		$35.3M Buy
789,226
+503,262
+176% +$22.3M 0.24% 99
2013
Q2 		$11.8M Buy
+285,964
New +$12.5M 0.08% 150

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Capital Guardian Trust's ABBV Position: Q2 2019 in Review

Capital Guardian Trust reduced its AbbVie (ABBV) stake by 8% in Q2 2019, selling an estimated $895K and leaving 130,955 shares worth $9.52M. The position accounts for 0.13% of the portfolio, ranked #135.

Capital Guardian Trust first reported a position in ABBV in Q2 2013 and has held it in 24 quarters since. The position peaked at $120M in Q2 2014. 2,021 funds tracked by Wall St. Rank hold ABBV as of Q2 2019.

  • Capital Guardian Trust held 130,955 shares of AbbVie worth $9.52M as of Q2 2019.
  • Capital Guardian Trust sold 11,382 AbbVie shares in Q2 2019, an estimated $895K.
  • AbbVie made up 0.13% of Capital Guardian Trust's portfolio in Q2 2019, its #135 holding.
  • Capital Guardian Trust first reported a position in AbbVie in Q2 2013 and has held it in 24 quarters since.
  • Capital Guardian Trust's AbbVie position peaked at $120M in Q2 2014.
  • 2,021 funds tracked by Wall St. Rank held AbbVie as of Q2 2019.

Based on Capital Guardian Trust's 13F filing for Q2 2019, filed 14 Aug 2019.